New hope for Australians living with brain cancer

Australians living with the most common and deadliest form of brain cancer will be given new hope. Thanks to a patient-focused clinical trial for Australians with Glioblastoma Multiforme (GBM)

Date published:
General public

The 2021 GBM AGILE grant opportunity is now open to Australian researchers.

Up to $12 million is available through the MRFF’s Australian Brain Cancer Mission in partnership with the Minderoo Foundation and Cure Brain Cancer Foundation for researchers to:

  • improve the health, wellbeing and survival outcomes of Australians with a diagnosis of GBM
  • further build Australia’s clinical trials capacity and infrastructure

See the media release for more information.

Help us improve

If you would like a response please use the enquiries form instead.